ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.465
      -0.38%
      Bitcoin
      65,176.75
      0.06%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Marker Therapeutics Inc (MRKR)

      7. Marker Therapeutics Inc (MRKR) News

      MRKR

      Marker Therapeutics (MRKR)

      Marker Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MRKR
      DateTimeSourceHeadlineSymbolCompany
      03/12/20204:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:34PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:33PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:04PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:MRKRMarker Therapeutics Inc
      03/12/20204:01PMPR Newswire (US)Marker Therapeutics Reports Full Year 2019 Operating and Financial ResultsNASDAQ:MRKRMarker Therapeutics Inc
      03/03/20204:43PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MRKRMarker Therapeutics Inc
      03/02/20209:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
      03/02/20207:00AMPR Newswire (US)Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 millionNASDAQ:MRKRMarker Therapeutics Inc
      02/20/20204:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      02/20/20204:25PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MRKRMarker Therapeutics Inc
      02/18/20207:00AMPR Newswire (US)Marker Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:MRKRMarker Therapeutics Inc
      02/14/20205:09PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MRKRMarker Therapeutics Inc
      02/11/20207:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
      02/11/20207:00AMPR Newswire (US)Marker Therapeutics Announces Update to its Clinical Program in AMLNASDAQ:MRKRMarker Therapeutics Inc
      11/25/20197:00AMPR Newswire (US)Marker Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:MRKRMarker Therapeutics Inc
      11/12/20194:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
      11/12/20194:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MRKRMarker Therapeutics Inc
      11/12/20194:01PMPR Newswire (US)Marker Therapeutics Reports Third Quarter 2019 Operating and Financial ResultsNASDAQ:MRKRMarker Therapeutics Inc
      11/11/20197:00AMPR Newswire (US)Marker Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast on Tuesday, Novemb...NASDAQ:MRKRMarker Therapeutics Inc
      09/24/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
      08/19/20195:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      08/19/20195:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MRKRMarker Therapeutics Inc
      08/15/20194:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
      08/15/20194:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
      08/15/20194:01PMPR Newswire (US)Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory AffairsNASDAQ:MRKRMarker Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:MRKR